Skip to main content

AutoGenomics

Premium
AutoGenomics announced Nov. 2 the release of a series of pharmacogenetic ASRs, including CYP 450 2C9 / VKORC1, which can be used to assess warfarin sensitivity.
 
Other applications for the new ASRs include CYP 450 2D6, 2C19, NAT2, UGT1A1, MDR1 and 3A4/3A5 tests.
 
AutoGenomics CEO Fareed Kureshy touted the achievement as “the most comprehensive panel of ASRs made available by any company” and said the achievement positioned the company as a leader in personalized medicine.
 

The company has also submitted a 510(k) application for an automated multiplexing microarray platform that can provide amplified samples to test results without manual intervention by the operator.

Filed under

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.